V Hemanth Kumar1, Nagendra Nayak Im2, Shobha V Huilgol3, Saeed M Yendigeri4, Narendar K1, Rajasekhar Ch5. 1. Lecturer, Department of Pharmacology, Al-Ameen Medical College , Bijapur, Karnataka, India . 2. Professor, Department of Pharmacology, K.S. Hegde Medical Academy, NITTE University , Mangalore, Karnataka, India . 3. Professor, Department of Pharmacology, Al-Ameen Medical College , Bijapur, Karnataka, India . 4. Associate Professor, Department of Pathology, Al-Ameen Medical College , Bijapur, Karnataka, India . 5. Tutor, Department of Pharmacology, KVG Medical College , Sullia, Karnataka, India .
Abstract
AIMS AND OBJECTIVES: To study the effect of dexamethasone on liver and endothelium, and to determine the optimum dose which induces the abnormal changes in liver and endothelium in Wistar rats. MATERIALS AND METHODS: Albino Wistar rats were divided into 7 groups (n=6). Control group rats received normal saline. Graded doses of dexamethasone (0.5,1,2,4,8 and 16mg/kg/ i.p.) was administered to the groups for six days. Liver and aorta were dissected at the end of the study and examined for histopathological changes under microscope. RESULTS: Intraperitoneal administration of dexamethasone (4,8 and 16mg/kg) for six days resulted in fatty changes in liver and same doses have shown thickening of endothelial layers in aorta, in comparison to control group. There were not much significant changes seen in low doses of dexamethasone (0.5, 1 and 2mg/kg). CONCLUSION: It is concluded that the acute high doses of dexamethasone (4,8 and 16mg/kg) for six days caused hepatic steatosis and showed mild to moderate arteriosclerosis in aorta. These changes may be secondary consequences of insulin resistance. Hence, it can be used as new animal model to screen the various plants and medicines in the treatment of insulin resistance.
AIMS AND OBJECTIVES: To study the effect of dexamethasone on liver and endothelium, and to determine the optimum dose which induces the abnormal changes in liver and endothelium in Wistar rats. MATERIALS AND METHODS: Albino Wistar rats were divided into 7 groups (n=6). Control group rats received normal saline. Graded doses of dexamethasone (0.5,1,2,4,8 and 16mg/kg/ i.p.) was administered to the groups for six days. Liver and aorta were dissected at the end of the study and examined for histopathological changes under microscope. RESULTS: Intraperitoneal administration of dexamethasone (4,8 and 16mg/kg) for six days resulted in fatty changes in liver and same doses have shown thickening of endothelial layers in aorta, in comparison to control group. There were not much significant changes seen in low doses of dexamethasone (0.5, 1 and 2mg/kg). CONCLUSION: It is concluded that the acute high doses of dexamethasone (4,8 and 16mg/kg) for six days caused hepatic steatosis and showed mild to moderate arteriosclerosis in aorta. These changes may be secondary consequences of insulin resistance. Hence, it can be used as new animal model to screen the various plants and medicines in the treatment of insulin resistance.
Authors: T Wallerath; K Witte; S C Schäfer; P M Schwarz; W Prellwitz; P Wohlfart; H Kleinert; H A Lehr; B Lemmer; U Förstermann Journal: Proc Natl Acad Sci U S A Date: 1999-11-09 Impact factor: 11.205
Authors: Carlos Bernal-Mizrachi; Sherry Weng; Chu Feng; Brian N Finck; Russell H Knutsen; Teresa C Leone; Trey Coleman; Robert P Mecham; Daniel P Kelly; Clay F Semenkovich Journal: Nat Med Date: 2003-07-06 Impact factor: 53.440
Authors: M Korach-André; J Gao; J S Gounarides; R Deacon; A Islam; D Laurent Journal: Am J Physiol Endocrinol Metab Date: 2004-08-24 Impact factor: 4.310
Authors: Stuart A Morgan; Mark Sherlock; Laura L Gathercole; Gareth G Lavery; Carol Lenaghan; Iwona J Bujalska; David Laber; Alice Yu; Gemma Convey; Rachel Mayers; Krisztina Hegyi; Jaswinder K Sethi; Paul M Stewart; David M Smith; Jeremy W Tomlinson Journal: Diabetes Date: 2009-08-12 Impact factor: 9.461
Authors: Barnabé Lucien Nkono Ya Nkono; Ablassé Rouamba; Mc Jesus Kinyok; Jean Guy Stéphane Omokolo; Balthazar Tchouanka Tcheudi; Benjamin Arnaud Tigui; Paul D Djomeni Dzeufiet; Sélestin Dongmo Sokeng; Pierre Kamtchouing Journal: Int J Appl Basic Med Res Date: 2022-07-26